Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing
In Bridge-TIMI 73a and SHASTA-2, the RNA-silencing therapies cut triglycerides quickly, offering hope for hard-to-treat patients.
Source: tctmd.com
Brian Bergmark News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Brian Bergmark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Brian Bergmark Today - Breaking & Trending Today
Early Olezarsen Results Show 50% Reduction in Triglycerides
A drug targeting mRNA essential for APO C-III production provided a 50% reduction in triglycerides in BRIDGE-TIMI 73a, the largest ever observed in a controlled trial.
Source: medscape.com
Study Finds Olezarsen Cuts Triglyceride Levels by About Half
Results show drug is effective and safe, leaves open question of optimal dosing
Source: dicardiology.com
Conference MDAngle: ACC 2024 Atherosclerosis and Lipid Management
Dr Erin D. Michos provides highlights from ACC 2024, including anticipated presentations, quick takeaways, and insights into how the presented research will impact patients.
Source: medscape.com
Stout Acquires Torrey Partners, Deepening Bench of Expert Consultants and Testifiers
/PRNewswire/ -- Stout announced the acquisition of Torrey Partners, an economic, forensic accounting, and valuation services firm headquartered in San Diego,...
Source: prnewswire.com